|
OSGIN2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.734000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.314800E-01 |
| Normal-vs-Stage2 |
9.655500E-02 |
| Normal-vs-Stage3 |
4.189800E-01 |
| Normal-vs-Stage4 |
7.843000E-01 |
| Stage1-vs-Stage2 |
2.748200E-02 |
| Stage1-vs-Stage3 |
8.869000E-01 |
| Stage1-vs-Stage4 |
7.750600E-01 |
| Stage2-vs-Stage3 |
2.296500E-02 |
| Stage2-vs-Stage4 |
8.831900E-02 |
| Stage3-vs-Stage4 |
6.937400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.983570E-01 |
| Normal-vs-AfricanAmerican |
2.773600E-01 |
| Normal-vs-Asian |
8.499400E-01 |
| Caucasian-vs-AfricanAmerican |
5.016800E-01 |
| Caucasian-vs-Asian |
5.097000E-01 |
| AfricanAmerican-vs-Asian |
3.293800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.378600E-01 |
| Normal-vs-Female |
4.060800E-01 |
| Male-vs-Female |
2.881800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.246010E-01 |
| Normal-vs-Age(41-60Yrs) |
8.891000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.813800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.980600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.092200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.682200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.106400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.347400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.295200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.582600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.900000E-02 |
| Classical-VS-Follicular |
2.71560551823313E-12 |
| Classical-VS-Other |
3.081200E-01 |
| Classical-VS-Normal |
4.510200E-02 |
| Tall-VS-Follicular |
4.4796999443264E-10 |
| Tall-VS-Other |
2.819700E-02 |
| Tall-VS-Normal |
1.538880E-03 |
| Follicular-VS-Other |
2.018400E-01 |
| Follicular-VS-Normal |
7.56889999999899E-05 |
| Other-VS-Normal |
5.482400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.052300E-02 |
| Normal-vs-N1 |
3.887200E-01 |
| N0-vs-N1 |
1.126030E-02 |
|
|
